Yu Gui Selected Research

N-acetyldopamine

1/2022

N-Acetyldopamine Dimer Attenuates DSS-Induced Ulcerative Colitis by Suppressing NF-κB and MAPK Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Gui Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 12/2022 - 11/2016
3	Vascular Diseases (Vascular Disease) 01/2022 - 02/2004
3	Leiomyoma (Uterine Fibroids) 01/2013 - 04/2011
2	Cicatrix (Scar) 02/2022 - 11/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2021
2	Atherosclerosis 01/2021 - 02/2004
2	Hypertension (High Blood Pressure) 02/2013 - 08/2007
2	Aneuploidy (Aneuploid) 03/2007 - 02/2006
1	Ulcerative Colitis 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Neoplasms (Cancer) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Disease Progression 01/2021
1	Postoperative Cognitive Complications 01/2019
1	Obesity 09/2017
1	Triple Negative Breast Neoplasms 07/2016
1	Fibrosis (Cirrhosis) 05/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2016
1	Cardiomegaly (Heart Hypertrophy) 02/2016
1	Hyperlipidemias (Hyperlipidemia) 04/2015
1	Body Weight (Weight, Body) 04/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2014
1	Muscular Atrophy (Muscle Atrophy) 10/2013
1	Neointima 12/2012
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 09/2007
1	Tuberous Sclerosis (Bourneville's Disease) 09/2007
1	Essential Hypertension 08/2007
1	Polyploidy 03/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 02/2006
2	2-MethoxyestradiolIBA 02/2013 - 03/2007
2	Estrogens (Estrogen)FDA Link 02/2013 - 01/2013
1	Proprotein Convertase 9IBA 01/2022
1	N-acetyldopamineIBA 01/2022
1	Ribonucleases (Ribonuclease)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	ChromatinIBA 01/2021
1	sortilinIBA 01/2021
1	LipidsIBA 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2019
1	LeptinIBA 09/2017
1	AdiponectinIBA 09/2017
1	ResistinIBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 09/2017
1	Nicotinamide PhosphoribosyltransferaseIBA 09/2017
1	AdipokinesIBA 09/2017
1	Interleukin-8 (Interleukin 8)IBA 09/2017
1	Biomarkers (Surrogate Marker)IBA 07/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2016
1	monoethylglycinexylidide (L 86)IBA 05/2016
1	Olive OilIBA 05/2016
1	Formaldehyde (Formol)FDA Link 05/2016
1	Lidocaine (Xylocaine)FDA LinkGeneric 05/2016
1	myocardinIBA 02/2016
1	Serum Response FactorIBA 02/2016
1	CelluloseIBA 04/2015
1	Hormones (Hormone)IBA 04/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2013
1	Desoxycorticosterone Acetate (DOCA)FDA Link 02/2013
1	SaltsIBA 02/2013
1	Desoxycorticosterone (Deoxycorticosterone)IBA 02/2013
1	Acetates (Acetic Acid Esters)FDA Link 02/2013
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013
1	GTP-Binding Proteins (G-Protein)IBA 01/2013
1	cyclopamineIBA 12/2012
1	Epidermal Growth Factor (EGF)IBA 10/2011
1	Mitogen-Activated Protein KinasesIBA 04/2011
1	Tuberous Sclerosis Complex 2 ProteinIBA 04/2011
1	lipoarabinomannan (LAM)IBA 09/2007
1	Vasoconstrictor AgentsIBA 08/2007
1	uridine adenosine tetraphosphateIBA 08/2007
1	Mercaptoethanol (2 Mercaptoethanol)IBA 02/2006
1	calphostin CIBA 02/2004

Therapy/Procedure

3	Mastectomy (Mammectomy) 12/2022 - 11/2016
3	Mammaplasty (Breast Reconstruction) 12/2022 - 11/2016
2	Prostheses and Implants (Prosthesis) 12/2022 - 02/2022
2	Drug Therapy (Chemotherapy) 07/2016 - 11/2014
1	Immunotherapy 04/2021
1	Ligation 01/2021
1	Therapeutics 01/2021
1	Prosthesis Implantation 11/2016
1	Subcutaneous Injections 05/2016